Popular breast cancer drugs don’t work the way we thought they did: Study suggests changes in so-called PARP inhibitors could boost potency, efficacy
Some of the most commonly used drugs for treating hereditary breast and ovarian cancers may not work the way we thought they did, according to new University of Colorado Boulder…